MEIER; Eddi
Patent Applications and Registrations
Patent applications and USPTO patent grants for MEIER; Eddi.The latest application filed is for "acylated glucagon analogues".
- MEIER; Eddi - Vaerlose DK
- Meier; Eddi - V.ae butted.rlose DK
| Patent | Date |
|---|---|
| Acylated Glucagon Analogues App 20190076506 - RIBER; Ditte ; et al. | 2019-03-14 |
| Acylated glucagon analogues Grant 10,004,786 - Riber , et al. June 26, 2 | 2018-06-26 |
| Glucagon Analogues App 20160304576 - MEIER; Eddi ; et al. | 2016-10-20 |
| Glucagon analogues Grant 9,403,894 - Meier , et al. August 2, 2 | 2016-08-02 |
| Acylated Glucagon Analogues App 20160120951 - RIBER; Ditte ; et al. | 2016-05-05 |
| Glucagon Analogues App 20150376257 - RIBER; Ditte ; et al. | 2015-12-31 |
| Glucagon analogues Grant 9,169,310 - Riber , et al. October 27, 2 | 2015-10-27 |
| Acylated glucagon analogues Grant 9,156,901 - Riber , et al. October 13, 2 | 2015-10-13 |
| Glucagon Analogues App 20150080295 - MEIER; Eddi ; et al. | 2015-03-19 |
| Glucagon Analogues App 20140127175 - MEIER; Eddi ; et al. | 2014-05-08 |
| Glucagon Analogues App 20140127174 - MEIER; Eddi ; et al. | 2014-05-08 |
| Glucagon analogues Grant 8,685,919 - Meier , et al. April 1, 2 | 2014-04-01 |
| Glucagon analogues Grant 8,680,049 - Meier , et al. March 25, 2 | 2014-03-25 |
| Glucagon analogues Grant 8,642,541 - Meier , et al. February 4, 2 | 2014-02-04 |
| Glucagon analogues Grant 8,642,540 - Meier , et al. February 4, 2 | 2014-02-04 |
| Glucagon Analogues App 20130157929 - Riber; Ditte ; et al. | 2013-06-20 |
| Glucagon Analogues App 20130157935 - Meier; Eddi ; et al. | 2013-06-20 |
| Treatment Of Cardiac Conditions App 20130157953 - Petersen; Jorgen Soberg ; et al. | 2013-06-20 |
| Acylated Glucagon Analogues App 20120178670 - Riber; Ditte ; et al. | 2012-07-12 |
| Glucagon Analogues App 20110293586 - Meier; Eddi ; et al. | 2011-12-01 |
| Glucagon Analogues App 20110293587 - Meier; Eddi ; et al. | 2011-12-01 |
| Glucagon Analogues App 20110286981 - Meier; Eddi ; et al. | 2011-11-24 |
| Glucagon Analogues App 20110286982 - Meier; Eddi ; et al. | 2011-11-24 |
| Glucagon analogues Grant 7,994,122 - Riber , et al. August 9, 2 | 2011-08-09 |
| Glucagon Analogues App 20100204105 - Riber; Ditte ; et al. | 2010-08-12 |
| Antiarrhythmic peptides Grant 7,737,113 - Larsen , et al. June 15, 2 | 2010-06-15 |
| Medical uses of intercellular communication facilitating compounds Grant 7,585,839 - Larsen , et al. September 8, 2 | 2009-09-08 |
| Compositions and methods for modulating connexin hemichannels App 20070042964 - Jensen; Peter Holme ; et al. | 2007-02-22 |
| Compositions and methods for modulating connexin hemichannels Grant 7,153,822 - Jensen , et al. December 26, 2 | 2006-12-26 |
| Medical uses of intercellular communication facilitating compounds App 20050113293 - Larsen, Bjarne Due ; et al. | 2005-05-26 |
| Novel antiarrythmic peptides App 20050075280 - Larsen, Bjarne Due ; et al. | 2005-04-07 |
| Compositions and methods for modulating guanylyl cyclase signaling receptor (gc-c) activity and for treating meniere's disease App 20040152868 - Larsen, Bjarne Due ; et al. | 2004-08-05 |
| Compositions and methods for modulating connexin hemichannels App 20040092429 - Jensen, Peter Holme ; et al. | 2004-05-13 |
| Novel antiarrythmic peptides App 20030092609 - Larsen, Bjarne Due ; et al. | 2003-05-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 